Parkman Healthcare Partners LLC Aclaris Therapeutics, Inc. Transaction History

Parkman Healthcare Partners LLC

$708 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$6.56 - $10.95 $340,063 - $567,637	-51,839 Reduced 26.78%	141,758 $971,000
Q2 2023 Aug 11, 2023	BUY	$7.89 - $10.64 $217,582 - $293,419	27,577 Added 16.61%	193,597 $2.01 Million
Q1 2023 May 12, 2023	SELL	$7.07 - $17.95 $573,652 - $1.46 Million	-81,139 Reduced 32.83%	166,020 $1.34 Million
Q4 2022 Feb 13, 2023	BUY	$14.33 - $18.37 $193,927 - $248,601	13,533 Added 5.79%	247,159 $3.89 Million
Q3 2022 Nov 14, 2022	SELL	$13.07 - $18.22 $930,806 - $1.3 Million	-71,217 Reduced 23.36%	233,626 $3.68 Million
Q2 2022 Aug 12, 2022	SELL	$10.16 - $17.08 $3.69 Million - $6.2 Million	-363,255 Reduced 54.37%	304,843 $4.26 Million
Q1 2022 May 13, 2022	SELL	$9.74 - $17.92 $3.48 Million - $6.41 Million	-357,424 Reduced 34.85%	668,098 $11.5 Million
Q4 2021 Feb 11, 2022	SELL	$12.27 - $18.49 $3.45 Million - $5.19 Million	-280,938 Reduced 21.5%	1,025,522 $14.9 Million
Q3 2021 Nov 12, 2021	SELL	$13.38 - $18.8 $2.61 Million - $3.67 Million	-195,000 Reduced 12.99%	1,306,460 $23.5 Million
Q2 2021 Aug 13, 2021	SELL	$17.08 - $29.6 $3.55 Million - $6.15 Million	-207,676 Reduced 12.15%	1,501,460 $26.4 Million
Q1 2021 May 14, 2021	SELL	$5.86 - $27.73 $973,932 - $4.61 Million	-166,200 Reduced 8.86%	1,709,136 $43.1 Million
Q4 2020 Feb 12, 2021	BUY	$2.65 - $7.61 $86,588 - $248,656	32,675 Added 1.77%	1,875,336 $12.1 Million
Q3 2020 Nov 13, 2020	BUY	$1.5 - $2.71 $217,956 - $393,773	145,304 Added 8.56%	1,842,661 $4.74 Million
Q2 2020 Aug 13, 2020	BUY	$1.04 - $1.73 $166,400 - $276,800	160,000 Added 10.41%	1,697,357 $2.75 Million
Q1 2020 May 15, 2020	BUY	$0.75 - $2.18 $984,267 - $2.86 Million	1,312,357 Added 583.27%	1,537,357 $1.6 Million
Q4 2019 Feb 13, 2020	BUY	$1.02 - $1.97 $229,500 - $443,250	225,000 New	225,000 $425,000

Others Institutions Holding ACRS

# of Institutions

Shares Held

50.7M

Call Options Held

30.6K

Put Options Held

Bml Capital Management, LLC Zionsville, IN

14.3M
Shares

$54.4 Million
9.64% of portfolio
Vanguard Group Inc Valley Forge, PA

4.69M
Shares

$17.9 Million
0.0% of portfolio
D. E. Shaw & Co., Inc. New York, NY

3.37M
Shares

$12.9 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.01M
Shares

$11.5 Million
0.0% of portfolio
Rock Springs Capital Management LP Baltimore, MD

2.75M
Shares

$10.5 Million
0.11% of portfolio

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $255M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkman Healthcare Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkman Healthcare Partners LLC with notifications on news.

Account